UY28969A1 - ALFA CRYSTAL FORM OF THE STRONTIUM RANELATE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT - Google Patents

ALFA CRYSTAL FORM OF THE STRONTIUM RANELATE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Info

Publication number
UY28969A1
UY28969A1 UY28969A UY28969A UY28969A1 UY 28969 A1 UY28969 A1 UY 28969A1 UY 28969 A UY28969 A UY 28969A UY 28969 A UY28969 A UY 28969A UY 28969 A1 UY28969 A1 UY 28969A1
Authority
UY
Uruguay
Prior art keywords
procedure
preparation
pharmaceutical compositions
compositions containing
crystal form
Prior art date
Application number
UY28969A
Other languages
Spanish (es)
Inventor
Stephane Horvath
Isabelle Demuynck
Gerard Damen
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Priority to UY28969A priority Critical patent/UY28969A1/en
Publication of UY28969A1 publication Critical patent/UY28969A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona forma cristalina alfa del ranelato de estroncio de fórmula (I) Caracterizada por su diagrama de difracción de rayos X de polvo y por un contenido de agua de 22 a 24%. MedicamentosAlpha crystalline form of the strontium ranelate of formula (I) is provided, characterized by its powder X-ray diffraction diagram and a water content of 22 to 24%. Medicines

UY28969A 2005-06-17 2005-06-17 ALFA CRYSTAL FORM OF THE STRONTIUM RANELATE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT UY28969A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY28969A UY28969A1 (en) 2005-06-17 2005-06-17 ALFA CRYSTAL FORM OF THE STRONTIUM RANELATE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY28969A UY28969A1 (en) 2005-06-17 2005-06-17 ALFA CRYSTAL FORM OF THE STRONTIUM RANELATE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Publications (1)

Publication Number Publication Date
UY28969A1 true UY28969A1 (en) 2005-11-30

Family

ID=38813069

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28969A UY28969A1 (en) 2005-06-17 2005-06-17 ALFA CRYSTAL FORM OF THE STRONTIUM RANELATE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Country Status (1)

Country Link
UY (1) UY28969A1 (en)

Similar Documents

Publication Publication Date Title
ECSP055859A (en) ALFA CRYSTALLINE FORM OF STRONTIUM RENELATO, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
ECSP088859A (en) NEW CRYSTAL FORM VI OF AGOMELATINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
AR053147A1 (en) CRYSTALINE FORM OF IVABRADINE CHLORHYDRATE, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
AR052925A1 (en) BABY CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
GT200600086A (en) GAMMA-D CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
EA200601271A1 (en) NEW CRYSTAL FORM IV OF AGOMELATIN, THE METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS
EA200601273A1 (en) NEW CRYSTAL FORM V AGOMELATIN, THE METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS
AR073298A1 (en) CRYSTAL FORMS OF 2-TIAZOLIL-4-QUINOLIL-OXI AMIDAS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF HCV INFECTION.
EA200601274A1 (en) NEW CRYSTAL FORM III OF AGOMELATIN, THE METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS
CR8647A (en) CRYSTALINE DELTA-D FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
AR029570A1 (en) NEW GAMMA CRYSTAL FORM OF PERINDOPRIL TERBUTILAMINE SALT, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
ECSP066915A (en) CRYSTALINE FORM DELTA OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
AR029571A1 (en) NEW BETA CRYSTALLINE FORM OF PERINDOPRIL TERBUTILAMINE SALT, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
MY151295A (en) Pyrimidyl indoline compound
AR075418A1 (en) CRYSTALLINE POLYMORPH OF 3 - {[5- (AZETIDIN-1-ILCARBONIL) PIRAZIN-2-IL] OXI} -5 - {[(1S) -1-METHYL-2- (METILOXI) ETIL] OXI} -N- ( 5-METHYLPIRAZIN-2-IL) BENZAMIDE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESS TO PREPARE IT AND USE OF THE SAME FOR THE TREATMENT OF TYPE II DIABETES AND / OR OBESITY.
AR034120A1 (en) HALOGENATED DERIVATIVE COMPOUND OF HEPTENOIC ACID 2-AMINO-4,5, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND THE USE OF SUCH COMPOUND AND SUCH COMPOSITION IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO INHIBIT OR MODULATE NITRIC ACID SYNTHESIS
BRPI0708278B8 (en) Crystalline form "a" of the arginine salt of perindopril, its use, process for its preparation and pharmaceutical composition
IN2012DN02502A (en)
NO20085317L (en) Imidazoazepinonforbindelser
BRPI0508232A (en) synthesis of epothilones, intermediates thereof, analogues and uses thereof
BRPI0407519A (en) benzofuran derivatives
MY157492A (en) Pharmaceutical composition 271
BRPI0602206B8 (en) polymorphic form of dexketoprofen trometamol and compositions containing it
UY28969A1 (en) ALFA CRYSTAL FORM OF THE STRONTIUM RANELATE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
AR065070A1 (en) ATORVASTATIN ESTRONIC SALT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20100722